Kuusi T, Palosuo T, Ehnholm C
Scand J Clin Lab Invest. 1985 May;45(3):245-53. doi: 10.3109/00365518509161002.
A consecutive immunonephelometric assay for human apolipoproteins (apo) A-I and A-II is described and validated. Apo A-II is first measured from guanidine-HCl-treated samples using a monospecific antiserum raised in sheep against purified apo A-II. This is followed by addition of anti apo A-I serum to the same tubes and recording of the light scattering after 90 min. The results of 125 serum samples were compared with those obtained by the radial immunodiffusion method, and thereby, correlation coefficients of 0.98 and 0.91 could be calculated for apo A-I and apo A-II concentrations, respectively. The within-assay variations of apo A-I and apo A-II methods were 3.28% and 2.40%, respectively, the corresponding inter-assay variations were 7.76% and 8.90%.
描述并验证了一种连续免疫比浊法检测人载脂蛋白(apo)A-I和A-II。首先使用针对纯化的apo A-II在绵羊中产生的单特异性抗血清,从经盐酸胍处理的样品中测量apo A-II。然后向同一试管中加入抗apo A-I血清,并在90分钟后记录光散射。将125份血清样本的结果与通过放射免疫扩散法获得的结果进行比较,从而分别计算出apo A-I和apo A-II浓度的相关系数为0.98和0.91。apo A-I和apo A-II方法的批内变异分别为3.28%和2.40%,相应的批间变异为7.76%和8.90%。